Diaceutics PLC (AIM: DXRX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
147.15
+0.15 (0.10%)
Jan 21, 2025, 12:33 PM GMT+1

Diaceutics Revenue

Diaceutics had revenue of 12.32M GBP in the half year ending June 30, 2024, with 63.66% growth. This brings the company's revenue in the last twelve months to 26.10M, up 19.16% year-over-year. In the year 2023, Diaceutics had annual revenue of 23.70M with 21.51% growth.

Revenue (ttm)
26.10M
Revenue Growth
+19.16%
P/S Ratio
4.75
Revenue / Employee
141.82K
Employees
184
Market Cap
124.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202323.70M4.20M21.51%
Dec 31, 202219.50M5.56M39.88%
Dec 31, 202113.94M1.25M9.82%
Dec 31, 202012.70M-746.00K-5.55%
Dec 31, 201913.44M3.07M29.58%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 38.20B
GSK plc 31.31B
Haleon 11.24B
Smith & Nephew 4.46B
ConvaTec Group 1.74B
Hikma Pharmaceuticals 2.39B
HUTCHMED (China) 483.31M
Oxford Nanopore Technologies 167.75M
Revenue Rankings